Jui-hung Tsai

No. 138, Sheng Li Road
Tainan, TNQ, Taiwan

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 19 publications

Cost-Effectiveness of First-Line Immunochemotherapy Versus BRAF Plus MEK Inhibitors in BRAFV600E-Mutated Metastatic Lung Cancer.

Cost-Effectiveness of First-Line Immunochemotherapy Versus BRAF Plus MEK Inhibitors in BRAFV600E-Mutated Metastatic Lung Cancer.

Journal: Current oncology (Toronto, Ont.)

Published: May 22, 2026

Correction: Cost Effectiveness of Exclusionary EGFR Testing for Taiwanese Patients Newly Diagnosed with Advanced Lung Adenocarcinoma.

Correction: Cost Effectiveness of Exclusionary EGFR Testing for Taiwanese Patients Newly Diagnosed with Advanced Lung Adenocarcinoma.

Journal: PharmacoEconomics

Published: December 17, 2025

Development and preliminary validation of a clinician-administered Chinese-language tool for breakthrough cancer pain assessment.

Development and preliminary validation of a clinician-administered Chinese-language tool for breakthrough cancer pain assessment.

Journal: Asia-Pacific journal of oncology nursing

Published: December 09, 2025

Cost-Effectiveness of Combination Amivantamab-Lazertinib, Osimertinib Plus Chemotherapy, and Osimertinib Monotherapy in Lung Cancer.

Cost-Effectiveness of Combination Amivantamab-Lazertinib, Osimertinib Plus Chemotherapy, and Osimertinib Monotherapy in Lung Cancer.

Journal: Journal of the National Comprehensive Cancer Network : JNCCN

Published: September 22, 2025

Interpretable machine learning approach for optimizing hospice care predictions using health assessment data.

Interpretable machine learning approach for optimizing hospice care predictions using health assessment data.

Journal: BMC medical informatics and decision making

Published: July 04, 2025

Cost-Effectiveness of Durvalumab After Chemoradiotherapy in Limited-Stage SCLC.

Cost-Effectiveness of Durvalumab After Chemoradiotherapy in Limited-Stage SCLC.

Journal: JTO clinical and research reports

Published: April 04, 2025

'Regrets become a lasting source of pain': A qualitative study on family caregivers' experiences leading up to a relative's death.

'Regrets become a lasting source of pain': A qualitative study on family caregivers' experiences leading up to a relative's death.

Journal: Palliative medicine

Published: February 10, 2025

Cost Effectiveness of Exclusionary EGFR Testing for Taiwanese Patients Newly Diagnosed with Advanced Lung Adenocarcinoma.

Cost Effectiveness of Exclusionary EGFR Testing for Taiwanese Patients Newly Diagnosed with Advanced Lung Adenocarcinoma.

Journal: PharmacoEconomics

Published: December 01, 2024

Correction to: The multinomial mixed‑effect regression model for predicting PCOC phases in hospice patients.

Correction to: The multinomial mixed‑effect regression model for predicting PCOC phases in hospice patients.

Journal: Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer

Published: November 10, 2024

Cost-effectiveness of lazertinib as first-line treatment in patients with EGFR-mutated advanced lung cancer.

Cost-effectiveness of lazertinib as first-line treatment in patients with EGFR-mutated advanced lung cancer.

Journal: Therapeutic advances in medical oncology

Published: October 10, 2024

'A good ending but not the end': Exploring family preparations surrounding a relative's death and the Afterlife - A qualitative study.

'A good ending but not the end': Exploring family preparations surrounding a relative's death and the Afterlife - A qualitative study.

Journal: Palliative medicine

Published: September 28, 2024

SnoRNA U50A mediates everolimus resistance in breast cancer through mTOR downregulation.

SnoRNA U50A mediates everolimus resistance in breast cancer through mTOR downregulation.

Journal: Translational oncology

Published: April 17, 2024

Showing 1-12 of 19

Last Updated: 09/26/2026